Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt
- 1 September 2013
- journal article
- Published by Elsevier in Value in Health Regional Issues
- Vol. 2 (2) , 319-327
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task ForceValue in Health, 2013
- Health Care System Information Sharing: A Step Toward Better Health GloballyValue in Health Regional Issues, 2012
- Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and developmentBritish Journal of Pharmacology, 2010
- Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part IValue in Health, 2010
- Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force ReportValue in Health, 2009
- Toward a Consensus on the QALYValue in Health, 2009
- QALYs: Some ChallengesValue in Health, 2009
- Key principles for the improved conduct of health technology assessments for resource allocation decisionsInternational Journal of Technology Assessment in Health Care, 2008
- AMCP Format Dossier Requests: Manufacturer Response and Formulary Implications for One Large Health PlanJournal of Managed Care Pharmacy, 2007
- The Academy of Managed Care Pharmacy Format for Formulary Submissions: An Evolving Standard—A Foundation for Managed Care Pharmacy Task Force ReportValue in Health, 2003